cigna glp-1 coverage news today Will Cover Ozempic®, Wegovy®, Mounjaro® or Zepbound™ for Weight Loss in Florida? Exclusive-Cigna drops coverage of GLP-1

Exposure to a social stressor induces translocation of commensal lactobacilli to the spleen and priming of the innate immune system

That is roughly double what semaglutide achieves at comparable doses

Effect of food consumption on the pharmacokinetics, safety, and tolerability of once-daily orally administered orforglipron (LY3502970), a non-peptide GLP-1 receptor agonist

NCCIH and NIH-affiliated researchers are clear that the optimal protein targets and training protocols during GLP-1 therapy are still being studied - the LEAN-PREP study and the GRAMS trial at Pennington Biomedical Research Center are both actively recruiting as of 2026